SAUDI GERMAN HEALTH
4009
Middle East Healthcare Co. (SAUDI GERMAN HEALTH)
35.68
(0.26) (0.72 %)

Financial Statement


USD Riyal
2025 2024 2023 2022
Details
Ar En
Ar En
Ar En
Ar En
Million Riyal Million Riyal Million Riyal Million Riyal
Income Statement
Revenue
Sales
3,102.63
2,882.82
2,653.17
2,151.74
Cost of Sales
(1,942.59)
(1,768.92)
(1,638.76)
(1,471.74)
Gross Income
1,160.04
1,113.90
1,014.41
680.01
Operating Income
387.30
440.93
323.97
140.34
Net Income
301.88
282.00
17.04
75.18
Shares Outstanding (Million)
92.04
92.04
92.04
92.04
Earning Per Share
3.28
3.06
0.19
0.82
Balance Sheet
Assets
Total Current Assets
2,256.50
2,173.39
2,536.33
1,957.00
Total Non-Current Assets
3,209.74
2,951.93
2,598.29
2,542.03
Total Assets
5,466.24
5,125.31
5,134.62
4,499.03
Liabilities
Total Current liabilities
1,456.93
1,261.90
2,135.22
1,630.56
Total Non-Current Liabilities
2,081.61
2,189.35
1,634.10
1,496.64
Total Liabilities
3,538.54
3,451.25
3,769.33
3,127.20
Owners Equity
Capital
920.40
920.40
920.40
920.40
Total Shareholders' Equity
1,872.36
1,626.11
1,319.61
1,328.63
Total Owners Equity
1,927.70
1,674.06
1,365.29
1,371.83
Cash Flow Statement
Operating Activities
Cash Flows from Operating Activities
544.60
766.00
191.08
76.02
Investing Activities
Cash Flows from Investing Activities
(338.37)
(508.82)
(241.99)
(249.40)
Financing Activities
Cash Flows from Financing Activities
(229.06)
(256.07)
77.95
160.85
Net change cash & cash equivalents
(22.84)
1.11
27.05
(12.53)
Cash & cash equiv at start of period
49.14
51.18
17.38
28.13
Cash & cash equiv at period end
26.30
52.28
44.42
15.60

×

Powered by Argaam.com